These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9385481)

  • 1. Nifedipine gastrointestinal therapeutic system (GITS) for hypertensive patients in a primary care setting: results of the Extended Release Adalat Canadian Trial (EXACT).
    Toal CB; Mahon WA; Barnes C; Burelle D
    Clin Ther; 1997; 19(5):924-35. PubMed ID: 9385481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy, tolerability, and quality of life of losartan, alone or with hydrochlorothiazide, versus nifedipine GITS in patients with essential hypertension.
    Weir MR; Elkins M; Liss C; Vrecenak AJ; Barr E; Edelman JM
    Clin Ther; 1996; 18(3):411-28. PubMed ID: 8829017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and tolerability of extended-release felodipine and extended-release nifedipine in patients with mild-to-moderate essential hypertension.
    Fagan TC; Haggert BE; Liss C
    Clin Ther; 1994; 16(4):634-46. PubMed ID: 7982251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood pressure control in patients with mild to moderate essential hypertension switched from nifedipine gastrointestinal therapeutic system (GITS) 30 mg to nifedipine GITS 20 mg.
    Toal CB;
    Clin Ther; 2001 Jan; 23(1):87-96. PubMed ID: 11219482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of long-acting nifedipine GITS/OROS monotherapy or combination therapy in hypertensive patients: results of a 12-week international, prospective, multicentre, observational study.
    Ueng KC; Ningling S; El Maksod A; Hung KY; Yuehui Y
    Clin Drug Investig; 2011; 31(9):631-42. PubMed ID: 21591818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prazosin GITS vs sustained release nifedipine in patients with hypertension and abnormal lipid profile: a randomized, controlled, multicenter study. Madras Hypertension Study Group.
    Misra KP; Joglekar SJ; Mukherjee S; Nanivadekar AS
    J Assoc Physicians India; 1998; Suppl 1():30-40. PubMed ID: 11233385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nifedipine gastrointestinal therapeutic system versus nifedipine coat-core: comparison of efficacy via 24-hour ambulatory blood pressure monitoring.
    Defina LF; Bookstaver DA; Goldfinger MP; Coffey TA
    Ann Pharmacother; 1997; 31(7-8):819-22. PubMed ID: 9220037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of nifedipine GITS and hydrochlorothiazide in the management of elderly patients with stage I-III diastolic hypertension.
    Dey HM; Soufer R; Hoffer P; Wackers FJ; Black HR
    Am J Hypertens; 1996 Jun; 9(6):598-606. PubMed ID: 8783785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of 24-hour ambulatory blood pressure data in hypertensive patients switched from nifedipine-GITS to nifedipine-CC.
    Wurdeman RL; Mooss AN; Mohiuddin SM; Lucas BD; Ryschon KL; Hilleman DE
    Pharmacotherapy; 1999 Jan; 19(1):94-100. PubMed ID: 9917082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination therapy with nifedipine GITS 60 mg: subanalysis of a prospective, 12-week observational study (AdADOSE).
    Motaweih AK; Usova E; Hussain W; Dello Z; Petri T
    Clin Exp Hypertens; 2016; 38(1):71-80. PubMed ID: 26331311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A postmarketing, open-label study to evaluate the tolerability and effectiveness of replacing standard-formulation doxazosin with doxazosin in the gastrointestinal therapeutic system formulation in adult patients with hypertension.
    Anegón M; Esteban J; Jiménez-García R; Sanz de Burgoa V; Martínez J; Gil de Miguel A
    Clin Ther; 2002 May; 24(5):786-97. PubMed ID: 12075946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of effects of controlled onset extended release verapamil at bedtime and nifedipine gastrointestinal therapeutic system on arising on early morning blood pressure, heart rate, and the heart rate-blood pressure product.
    White WB; Black HR; Weber MA; Elliott WJ; Bryzinski B; Fakouhi TD
    Am J Cardiol; 1998 Feb; 81(4):424-31. PubMed ID: 9485131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nifedipine gastrointestinal therapeutic system in the treatment of hypertension. Results of a multicenter trial. The Modern Approach to the Treatment of Hypertension (MATH) Study Group.
    Krakoff LR; Bravo EL; Tuck ML; Friedman CP
    Am J Hypertens; 1990 Dec; 3(12 Pt 2):318S-325S. PubMed ID: 2078318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of a low dose nifedipine GITS (20 mg) in patients with mild to moderate hypertension.
    Toal CB
    Can J Cardiol; 1997 Oct; 13(10):921-7. PubMed ID: 9374948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effects of felodipine ER, amlodipine and nifedipine GITS on 24 h blood pressure control and trough to peak ratios in mild to moderate ambulatory hypertension: a forced titration study.
    Lefebvre J; Poirier L; Archambault F; Jewell D; Reed CV; Lacourcière Y
    Can J Cardiol; 1998 May; 14(5):682-8. PubMed ID: 9627524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine.
    Kes S; Caglar N; Canberk A; Deger N; Demirtas M; Dortlemez H; Kiliccioglu B; Kozan O; Ovunc K; Turkoglu C
    Curr Med Res Opin; 2003; 19(3):226-37. PubMed ID: 12803737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy and safety of once-daily nifedipine: the coat-core formulation compared with the gastrointestinal therapeutic system formulation in patients with mild-to-moderate diastolic hypertension. Nifedipine Study Group.
    Glasser SP; Jain A; Allenby KS; Shannon T; Pride K; Pettis PP; Schwartz LA; MacCarthy EP
    Clin Ther; 1995; 17(1):12-29. PubMed ID: 7758054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihypertensive effectiveness of nifedipine gastrointestinal therapeutic system in the elderly. The Modern Approach to the Treatment of Hypertension (MATH) Study Group.
    Bravo EL; Krakoff LR; Tuck ML; Friedman CP
    Am J Hypertens; 1990 Dec; 3(12 Pt 2):326S-332S. PubMed ID: 2078319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of nifedipine GITS in Asians with hypertension: results of a post-marketing surveillance study in China.
    Runlin G; Junren Z; Guozhang L; Weizhong Z; Tingjie Z; Ningling S; Landen H
    Clin Drug Investig; 2007; 27(8):565-72. PubMed ID: 17638397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early intervention of long-acting nifedipine GITS reduces brachial-ankle pulse wave velocity and improves arterial stiffness in Chinese patients with mild hypertension: a 24-week, single-arm, open-label, prospective study.
    Zhang J; Wang Y; Hu H; Yang X; Tian Z; Liu D; Gu G; Zheng H; Xie R; Cui W
    Drug Des Devel Ther; 2016; 10():3399-3406. PubMed ID: 27799740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.